AMGN: Amgen Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 123,538.41
Enterprise Value ($M) 154,696.89
Book Value ($M) 10,832.00
Book Value / Share 17.63
Price / Book 11.57
NCAV ($M) n/a
NCAV / Share n/a
Price / NCAV n/a

Profitability (mra)
Return on Invested Capital (ROIC) 0.17
Return on Assets (ROA) 0.10
Return on Equity (ROE) 0.33

Liquidity (mrq)
Quick Ratio 2.53
Current Ratio 2.77

Balance Sheet (mrq) ($M)
Current Assets 35,151.00
Assets 63,997.00
Liabilities 53,165.00
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 23,747.00
Operating Income 10,263.00
Net Income 8,394.00
Earnings Per Share Basic 12.70
Earnings Per Share Diluted 12.62

Cash Flow Statement (mra) ($M)
Cash From Operations 11,296.00
Cash from Investing 14,339.00
Cash from Financing 14,339.00

Source:
Fintel.io

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
2019-02-13 13G/A Capital Research Global Investors 5.50 -30.98
2019-02-13 13G/A FMR LLC / Fidelity 5.20 -36.17
2019-02-11 13G/A BlackRock Inc. 7.20 -6.69
2019-02-11 13G/A Vanguard Group Inc 7.83 -4.62

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

Source:
Fintel.io

Date Insider Trades Code Shares Value

Source:
Fintel.io

File Date Form SEC Filings
2019-07-31 10-Q AMGN / Amgen Inc. 10-Q – Quarterly Report – 10-Q
2019-05-01 10-Q AMGN / Amgen Inc. 10-Q Quarterly Report 10-Q
2019-02-13 10-K AMGN / Amgen Inc. 10-K (Annual Report)
2018-10-31 10-Q AMGN / Amgen Inc. 10-Q (Quarterly Report)

Source:
Fintel.io

Similar Companies
ALXN – Alexion Pharmaceuticals, Inc. AMAG – AMAG Pharmaceuticals, Inc.
AMBI – Ambit Biosciences Corp AMPH – Amphastar Pharmaceuticals, Inc.
AMRN – Amarin Corp. Plc


Financial data and stock pages provided for FREE by
Fintel.io